NEVRO CORP Insider Trading for May 2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in NEVRO CORP.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in NEVRO CORP for May 2017.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 30 2017 | NVRO | NEVRO CORP | DEMANE MICHAEL F | Director | Option Exercise | A | 74.07 | 3,545 | 262,578 | 3,545 | |
| May 30 2017 | NVRO | NEVRO CORP | DEMANE MICHAEL F | Director | Grant | A | 0.00 | 1,518 | 0 | 487,313 | 485.8 K to 487.3 K (+0.31 %) |
| May 30 2017 | NVRO | NEVRO CORP | Vale Brad | Director | Option Exercise | A | 74.07 | 3,545 | 262,578 | 3,545 | |
| May 30 2017 | NVRO | NEVRO CORP | Vale Brad | Director | Grant | A | 0.00 | 1,518 | 0 | 3,518 | 2 K to 3.5 K (+75.90 %) |
| May 30 2017 | NVRO | NEVRO CORP | Behbahani Ali | Director | Option Exercise | A | 74.07 | 3,545 | 262,578 | 3,545 | |
| May 30 2017 | NVRO | NEVRO CORP | Behbahani Ali | Director | Grant | A | 0.00 | 1,518 | 0 | 1,565 | 47 to 1.6 K (+3,229.79 %) |
| May 30 2017 | NVRO | NEVRO CORP | McCormick Shawn | Director | Option Exercise | A | 74.07 | 3,545 | 262,578 | 3,545 | |
| May 30 2017 | NVRO | NEVRO CORP | McCormick Shawn | Director | Grant | A | 0.00 | 1,518 | 0 | 1,518 | 0 to 1.5 K |
| May 30 2017 | NVRO | NEVRO CORP | JAEGER WILFRED E | Director | Option Exercise | A | 74.07 | 3,545 | 262,578 | 3,545 | |
| May 30 2017 | NVRO | NEVRO CORP | JAEGER WILFRED E | Director | Grant | A | 0.00 | 1,518 | 0 | 1,518 | 0 to 1.5 K |
| May 30 2017 | NVRO | NEVRO CORP | Fischer Frank M | Director | Option Exercise | A | 74.07 | 3,545 | 262,578 | 3,545 | |
| May 30 2017 | NVRO | NEVRO CORP | Fischer Frank M | Director | Grant | A | 0.00 | 1,518 | 0 | 60,518 | 59 K to 60.5 K (+2.57 %) |
| May 30 2017 | NVRO | NEVRO CORP | Earnhardt Lisa D | Director | Option Exercise | A | 74.07 | 3,545 | 262,578 | 3,545 | |
| May 30 2017 | NVRO | NEVRO CORP | Earnhardt Lisa D | Director | Grant | A | 0.00 | 1,518 | 0 | 1,518 | 0 to 1.5 K |
| May 16 2017 | NVRO | NEVRO CORP | Galligan Andrew H | Chief Financial Off ... | Option Exercise | M | 3.60 | 7,500 | 27,000 | 44,546 | |
| May 16 2017 | NVRO | NEVRO CORP | Galligan Andrew H | Chief Financial Off ... | Sell | S | 76.40 | 1,306 | 99,782 | 11,833 | 13.1 K to 11.8 K (-9.94 %) |
| May 16 2017 | NVRO | NEVRO CORP | Galligan Andrew H | Chief Financial Off ... | Sell | S | 75.55 | 2,698 | 203,826 | 13,139 | 15.8 K to 13.1 K (-17.04 %) |
| May 16 2017 | NVRO | NEVRO CORP | Galligan Andrew H | Chief Financial Off ... | Sell | S | 74.69 | 3,496 | 261,126 | 15,837 | 19.3 K to 15.8 K (-18.08 %) |
| May 16 2017 | NVRO | NEVRO CORP | Galligan Andrew H | Chief Financial Off ... | Buy | M | 3.60 | 7,500 | 27,000 | 19,333 | 11.8 K to 19.3 K (+63.38 %) |
| May 11 2017 | NVRO | NEVRO CORP | Galligan Andrew H | Chief Financial Off ... | Option Exercise | M | 1.44 | 5,000 | 7,200 | 22,404 | |
| May 11 2017 | NVRO | NEVRO CORP | Galligan Andrew H | Chief Financial Off ... | Buy | M | 1.44 | 5,000 | 7,200 | 11,833 | 6.8 K to 11.8 K (+73.17 %) |
| May 03 2017 | NVRO | NEVRO CORP | Elghandour Rami | President & CEO | Option Exercise | M | 3.60 | 10,000 | 36,000 | 65,051 | |
| May 03 2017 | NVRO | NEVRO CORP | Elghandour Rami | President & CEO | Sell | S | 95.03 | 10,000 | 950,302 | 95,224 | 105.2 K to 95.2 K (-9.50 %) |
| May 03 2017 | NVRO | NEVRO CORP | Elghandour Rami | President & CEO | Buy | M | 3.60 | 10,000 | 36,000 | 105,224 | 95.2 K to 105.2 K (+10.50 %) |
| May 03 2017 | NVRO | NEVRO CORP | DEMANE MICHAEL F | Director | Sell | S | 97.00 | 16,000 | 1,552,000 | 485,795 | 501.8 K to 485.8 K (-3.19 %) |
| May 03 2017 | NVRO | NEVRO CORP | DEMANE MICHAEL F | Director | Sell | S | 95.00 | 13,800 | 1,311,000 | 501,795 | 515.6 K to 501.8 K (-2.68 %) |